TREM-2: friend or foe in infectious diseases?

References

• Achim CL, Adame A, Dumaop W, Everall IP, Masliah E, Neurobehavioral Research Center. 2009. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol. 4(2):190–199.
   PubMed Web of Science ®Google Scholar
• Allcock RJ, Barrow AD, Forbes S, Beck S, Trowsdale J. 2003. The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur J Immunol. 33(2):567–577.
   PubMed Web of Science ®Google Scholar
• Andoh NE, Gyan BA. 2021. The potential roles of glial cells in the neuropathogenesis of cerebral malaria. Front Cell Infect Microbiol. 11:741370.
   PubMed Web of Science ®Google Scholar
• Aoki N, Zganiacz A, Margetts P, Xing Z. 2004. Differential regulation of DAP12 and molecules associated with DAP12 during host responses to mycobacterial infection. Infect Immun. 72(5):2477–2483.
   PubMed Web of Science ®Google Scholar
• Babu S, Blauvelt CP, Kumaraswami V, Nutman TB. 2005. Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation. J Immunol. 175(2):1170–1176.
   PubMed Web of Science ®Google Scholar
• Begum NA, Ishii K, Kurita-Taniguchi M, Tanabe M, Kobayashi M, Moriwaki Y, Matsumoto M, Fukumori Y, Azuma I, Toyoshima K, et al. 2004. Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages. Infect Immun. 72(2):937–948.
   PubMed Web of Science ®Google Scholar
• Berner DK, Wessolowski L, Armbrust F, Schneppenheim J, Schlepckow K, Koudelka T, Scharfenberg F, Lucius R, Tholey A, Kleinberger G, et al. 2020. Meprin β cleaves TREM2 and controls its phagocytic activity on macrophages. FASEB J. 34(5):6675–6687.
   PubMed Web of Science ®Google Scholar
• Bortolotti D, Gentili V, Rotola A, Caselli E, Rizzo R. 2019. HHV-6A infection induces amyloid-beta expression and activation of microglial cells. Alzheimers Res Ther. 11(1):104.
   PubMed Web of Science ®Google Scholar
• Bouchon A, Dietrich J, Colonna M. 2000. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 164(10):4991–4995.
   PubMed Web of Science ®Google Scholar
• Bouchon A, Hernández-Munain C, Cella M, Colonna M. 2001. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med. 194(8):1111–1122.
   PubMed Web of Science ®Google Scholar
• Boza-Serrano A, Ruiz R, Sanchez-Varo R, García-Revilla J, Yang Y, Jimenez-Ferrer I, Paulus A, Wennström M, Vilalta A, Allendorf D, et al. 2019. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease. Acta Neuropathol. 138(2):251–273.
   PubMed Web of Science ®Google Scholar
• Byers DE, Alexander-Brett J, Patel AC, Agapov E, Dang-Vu G, Jin X, Wu K, You Y, Alevy Y, Girard JP, et al. 2013. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest. 123(9):3967–3982.
   PubMed Web of Science ®Google Scholar
• Chai Q, Lu Z, Liu CH. 2020. Host defense mechanisms against Mycobacterium tuberculosis. Cell Mol Life Sci. 77(10):1859–1878.
   PubMed Web of Science ®Google Scholar
• Chang JH, Chang EJ, Kim HH, Kim SK. 2009. Enhanced inhibitory effects of a novel CpG motif on osteoclast differentiation via TREM-2 down-regulation. Biochem Biophys Res Commun. 389(1):28–33.
   PubMed Web of Science ®Google Scholar
• Charles JF, Humphrey MB, Zhao X, Quarles E, Nakamura MC, Aderem A, Seaman WE, Smith KD. 2008. The innate immune response to Salmonella enterica serovar Typhimurium by macrophages is dependent on TREM2-DAP12. Infect Immun. 76(6):2439–2447.
   PubMed Web of Science ®Google Scholar
• Chen LC, Laskin JD, Gordon MK, Laskin DL. 2008. Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. Exp Mol Pathol. 84(2):145–155.
   PubMed Web of Science ®Google Scholar
• Chen Q, Yang Y, Wu X, Yang S, Zhang Y, Shu Q, Fang X. 2021. Triggering receptor expressed on myeloid cells-2 protects aged mice against sepsis by mitigating the IL-23/IL-17A response. Shock. 56(1):98–107.
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang K, Jin Y, Zhu T, Cheng B, Shu Q, Fang X. 2013. Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance. Am J Respir Crit Care Med. 188(2):201–212.
   PubMed Web of Science ®Google Scholar
• Chen WH, Toapanta FR, Shirey KA, Zhang L, Giannelou A, Page C, Frieman MB, Vogel SN, Cross AS. 2012. Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza. Immunol Lett. 141(2):227–234.
   PubMed Web of Science ®Google Scholar
• Chouery E, Delague V, Bergougnoux A, Koussa S, Serre JL, Mégarbané A. 2008. Mutations in TREM2 lead to pure early-onset dementia without bone cysts. Hum Mutat. 29(9):E194–E204.
   PubMed Web of Science ®Google Scholar
• Coelho I, Duarte N, Barros A, Macedo MP, Penha-Gonçalves C. 2021. Trem-2 promotes emergence of restorative macrophages and endothelial cells during recovery from hepatic tissue damage. Front Immunol. 11:616044.
   PubMed Web of Science ®Google Scholar
• Colonna M. 2003. TREMs in the immune system and beyond. Nat Rev Immunol. 3(6):445–453.
   PubMed Web of Science ®Google Scholar
• Correale C, Genua M, Vetrano S, Mazzini E, Martinoli C, Spinelli A, Arena V, Peyrin-Biroulet L, Caprioli F, Passini N, et al. 2013. Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response. Gastroenterology. 144(2):346–356.e3.
   PubMed Web of Science ®Google Scholar
• Cuyvers E, Bettens K, Philtjens S, Van Langenhove T, Gijselinck I, van der Zee J, Engelborghs S, Vandenbulcke M, Van Dongen J, Geerts N, et al. 2014. Investigating the role of rare heterozygous TREM2 variants in Alzheimer’s disease and frontotemporal dementia. Neurobiol Aging. 35(3):726.e11.
   PubMed Web of Science ®Google Scholar
• Daws MR, Lanier LL, Seaman WE, Ryan JC. 2001. Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur J Immunol. 31(3):783–791.
   PubMed Web of Science ®Google Scholar
• Daws MR, Sullam PM, Niemi EC, Chen TT, Tchao NK, Seaman WE. 2003. Pattern recognition by TREM-2: binding of anionic ligands. J Immunol. 171(2):594–599.
   PubMed Web of Science ®Google Scholar
• de Lange A, Mahanty S, Raimondo JV. 2019. Model systems for investigating disease processes in neurocysticercosis. Parasitology. 146(5):553–562.
   PubMed Web of Science ®Google Scholar
• de Nooijer AH, Grondman I, Lambden S, Kooistra EJ, Janssen NAF, Kox M, Pickkers P, Joosten LAB, van de Veerdonk FL, Derive M, et al. 2021. Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19. Biosci Rep. 41:BSR20210940.
   PubMed Web of Science ®Google Scholar
• de Oliveira YLM, de Sá Resende A, Martins-Filho PR, de Moura TR. 2022. Role of triggering receptor expressed on myeloid cells-1 (TREM-1) in COVID-19 and other viral pneumonias: a systematic review and meta-analysis of clinical studies. Inflammopharmacology. 30:1037–1045.
   PubMed Web of Science ®Google Scholar
• Dean HB, Roberson ED, Song Y. 2019. Neurodegenerative disease–associated variants in TREM2 destabilize the apical ligand-binding region of the immunoglobulin domain. Front Neurol. 10:1252.
   PubMed Web of Science ®Google Scholar
• Deczkowska A, Weiner A, Amit I. 2020. The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell. 181(6):1207–1217.
   PubMed Web of Science ®Google Scholar
• Edén A, Marcotte TD, Heaton RK, Nilsson S, Zetterberg H, Fuchs D, Franklin D, Price RW, Grant I, Letendre SL, et al. 2016. Increased intrathecal immune activation in virally suppressed HIV-1 infected patients with neurocognitive impairment. PLoS One. 11(6):e0157160.
   PubMed Web of Science ®Google Scholar
• Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, Rodriguez AS, Mitchell T, Washicosky KJ, György B, Breakefield XO, Tanzi RE, Moir RD. 2018. Alzheimer’s disease-associated β-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron. 99(1):56–63.e3.
   PubMed Web of Science ®Google Scholar
• Elliott R, Li F, Dragomir I, Chua MM, Gregory BD, Weiss SR. 2013. Analysis of the host transcriptome from demyelinating spinal cord of murine coronavirus-infected mice. PLoS One. 8(9):e75346.
   PubMed Web of Science ®Google Scholar
• Ferrara SJ, Chaudhary P, DeBell MJ, Marracci G, Miller H, Calkins E, Pocius E, Napier BA, Emery B, Bourdette D, et al. 2022. TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor. Cell Chem Biol. 29(2):239–248.e4.
   PubMed Web of Science ®Google Scholar
• Feuerbach D, Schindler P, Barske C, Joller S, Beng-Louka E, Worringer KA, Kommineni S, Kaykas A, Ho DJ, Ye C, et al. 2017. ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine. Neurosci Lett. 660(157):109–114.
   PubMedGoogle Scholar
• Fields JA, Spencer B, Swinton M, Qvale EM, Marquine MJ, Alexeeva A, Gough S, Soontornniyomkij B, Valera E, Masliah E, et al. 2018. Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. J Neurochem. 147(6):784–802.
   PubMed Web of Science ®Google Scholar
• French T, Düsedau HP, Steffen J, Biswas A, Ahmed N, Hartmann S, Schüler T, Schott BH, Dunay IR. 2019. Neuronal impairment following chronic Toxoplasma gondii infection is aggravated by intestinal nematode challenge in an IFN-γ-dependent manner. J Neuroinflammation. 16(1):159.
   PubMedGoogle Scholar
• Gawish R, Martins R, Böhm B, Wimberger T, Sharif O, Lakovits K, Schmidt M, Knapp S. 2015. Triggering receptor expressed on myeloid cells-2 fine-tunes inflammatory responses in murine Gram-negative sepsis. FASEB J. 29(4):1247–1257.
   PubMed Web of Science ®Google Scholar
• Geijtenbeek TBH, Gringhuis SI. 2009. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol. 9(7):465–479.
   PubMed Web of Science ®Google Scholar
• Ghosh J, Guha R, Das S, Roy S. 2014. Liposomal cholesterol delivery activates the macrophage innate immune arm to facilitate intracellular Leishmania donovani killing. Infect Immun. 82(2):607–617.
   PubMed Web of Science ®Google Scholar
• Gisslén M, Heslegrave A, Veleva E, Yilmaz A, Andersson LM, Hagberg L, Spudich S, Fuchs D, Price RW, Zetterberg H. 2019. CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection. Neurol Neuroimmunol Neuroinflamm. 6(1):e512.
   PubMed Web of Science ®Google Scholar
• Gonçalves LA, Rodrigues-Duarte L, Rodo J, Vieira de Moraes L, Marques I, Penha-Gonçalves C. 2013. TREM2 governs Kupffer cell activation and explains belr1 genetic resistance to malaria liver stage infection. Proc Natl Acad Sci U S A. 110(48):19531–19536.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Cotto M, Palmieri EM, Baseler WA, Rice CM, McVicar DW. 2020. Trem2 supports the metabolic program of alternative activated macrophages. 204:73.19–73.19.
   Google Scholar
• Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, et al. 2013. TREM2 variants in Alzheimer’s disease. N Engl J Med. 368(2):117–127.
   PubMed Web of Science ®Google Scholar
• Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL. 2006. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol. 177(4):2051–2055.
   PubMed Web of Science ®Google Scholar
• Hermes G, Ajioka JW, Kelly KA, Mui E, Roberts F, Kasza K, Mayr T, Kirisits MJ, Wollmann R, Ferguson DJ, et al. 2008. Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation. 5:48.
   PubMed Web of Science ®Google Scholar
• Herrick JA, Bustos JA, Clapham P, Garcia HH, Loeb JA, Cysticercosis Working Group in Peru. 2020. Unique characteristics of epilepsy development in neurocysticercosis. Am J Trop Med Hyg. 103(2):639–645.
   PubMed Web of Science ®Google Scholar
• Hiremath J, Renu S, Tabynov K, Renukaradhya GJ. 2020. Pulmonary inflammatory response to influenza virus infection in pigs is regulated by DAP12 and macrophage M1 and M2 phenotypes. Cell Immunol. 352:104078.
   PubMed Web of Science ®Google Scholar
• Holtzman MJ. 2012. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest. 122(8):2741–2748.
   PubMed Web of Science ®Google Scholar
• Hoogendijk AJ, Blok DC, Garcia Laorden MI, Kager LM, Lede IO, Rahman W, Afroz R, Bresser P, van der Zee JS, Ghose A, et al. 2015. Soluble and cell-associated triggering receptor expressed on myeloid cells-1 and -2 in patients with pulmonary tuberculosis. J Infect. 71(6):706–709.
   PubMed Web of Science ®Google Scholar
• Iizasa E, Chuma Y, Uematsu T, Kubota M, Kawaguchi H, Umemura M, Toyonaga K, Kiyohara H, Yano I, Colonna M, et al. 2021. TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation. Nat Commun. 12(1):2299.
   PubMed Web of Science ®Google Scholar
• Istomin AY, Godzik A. 2009. Understanding diversity of human innate immunity receptors: analysis of surface features of leucine-rich repeat domains in NLRs and TLRs. BMC Immunol. 10:48.
   PubMed Web of Science ®Google Scholar
• Ito H, Hamerman JA. 2012. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur J Immunol. 42(1):176–185.
   PubMed Web of Science ®Google Scholar
• Ji KY, Kim SM, Yee SM, Kim MJ, Ban YJ, Kim EM, Lee EH, Choi HR, Yun H, Lee CW, et al. 2021. Cyclophilin A is an endogenous ligand for the triggering receptor expressed on myeloid cells-2 (TREM2). FASEB J. 35(4):e21479.
   PubMed Web of Science ®Google Scholar
• Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. 2001. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol. 154(4):357–365.
   PubMed Web of Science ®Google Scholar
• Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, et al. 2013. Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med. 368(2):107–116.
   PubMed Web of Science ®Google Scholar
• Joseph SB, Arrildt KT, Sturdevant CB, Swanstrom R. 2015. HIV-1 target cells in the CNS. J Neurovirol. 21(3):276–289.
   PubMed Web of Science ®Google Scholar
• Jung BK, Pyo KH, Shin KY, Hwang YS, Lim H, Lee SJ, Moon JH, Lee SH, Suh YH, Chai JY, et al. 2012. Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer’s disease. PLoS One. 7(3):e33312.
   PubMed Web of Science ®Google Scholar
• Kalliolias GD, Zhao B, Triantafyllopoulou A, Park-Min KH, Ivashkiv LB. 2010. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Arthritis Rheum. 62(2):402–413.
   PubMedGoogle Scholar
• Kawabori M, Kacimi R, Kauppinen T, Calosing C, Kim JY, Hsieh CL, Nakamura MC, Yenari MA. 2015. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J Neurosci. 35(8):3384–3396.
   PubMed Web of Science ®Google Scholar
• Keegan AD, Shirey KA, Bagdure D, Blanco J, Viscardi RM, Vogel SN. 2016. Enhanced allergic responsiveness after early childhood infection with respiratory viruses: are long-lived alternatively activated macrophages the missing link? Pathog Dis. 74:ftw047.
   PubMed Web of Science ®Google Scholar
• Kerget F, Kerget B, Yılmaz Sİ, Kızıltunç A. 2021. Evaluation of the relationship between TREM-1/TREM-2 ratio and clinical course in COVID-19 pneumonia. Int J Clin Pract. 75(10):e14697.
   PubMedGoogle Scholar
• Kim EY, Battaile JT, Patel AC, You Y, Agapov E, Grayson MH, Benoit LA, Byers DE, Alevy Y, Tucker J, et al. 2008. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med. 14(6):633–640.
   PubMed Web of Science ®Google Scholar
• Klesney-Tait J, Turnbull IR, Colonna M. 2006. The TREM receptor family and signal integration. Nat Immunol. 7(12):1266–1273.
   PubMed Web of Science ®Google Scholar
• Knight AC, Brill SA, Solis CV, Richardson MR, McCarron ME, Queen SE, Bailey CC, Mankowski JL. 2020. Differential regulation of TREM2 and CSF1R in CNS macrophages in an SIV/macaque model of HIV CNS disease. J Neurovirol. 26(4):511–519.
   PubMed Web of Science ®Google Scholar
• Kober DL, Alexander-Brett JM, Karch CM, Cruchaga C, Colonna M, Holtzman MJ, Brett TJ. 2016. Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms. Elife. 5:e20391.
   PubMed Web of Science ®Google Scholar
• Kober DL, Brett TJ. 2017. TREM2-ligand interactions in health and disease. J Mol Biol. 429(11):1607–1629.
   PubMed Web of Science ®Google Scholar
• Kober DL, Stuchell-Brereton MD, Kluender CE, Dean HB, Strickland MR, Steinberg DF, Nelson SS, Baban B, Holtzman DM, Frieden C, et al. 2021. Functional insights from biophysical study of TREM2 interactions with apoE and Aβ. Alzheimers Dement. 17:475–488.
   Web of Science ®Google Scholar
• Kosack L, Gawish R, Lercher A, Vilagos B, Hladik A, Lakovits K, Bhattacharya A, Schliehe C, Mesteri I, Knapp S, et al. 2017. The lipid-sensor TREM2 aggravates disease in a model of LCMV-induced hepatitis. Sci Rep. 7(1):11289.
   PubMedGoogle Scholar
• Laudanski K, Hajj J, Restrepo M, Siddiq K, Okeke T, Rader DJ. 2021. Dynamic changes in central and peripheral neuro-injury vs. neuroprotective serum markers in COVID-19 are modulated by different types of anti-viral treatments but do not affect the incidence of late and early strokes. Biomedicines. 9(12):1791.
   PubMed Web of Science ®Google Scholar
• Lee HY, Lee EH, Yi J, Ji KY, Kim SM, Choi HR, Yee SM, Kang HS, Kim EM. 2021. TREM2 promotes natural killer cell development in CD3(−)CD122(+)NK1.1(+) pNK cells. BMC Immunol. 22(1):30.
   PubMed Web of Science ®Google Scholar
• Lefterov I, Schug J, Mounier A, Nam KN, Fitz NF, Koldamova R. 2015. RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment. Neurobiol Dis. 82:132–140.
   PubMed Web of Science ®Google Scholar
• Li D, Wu M. 2021. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 6(1):291.
   PubMed Web of Science ®Google Scholar
• Lin WR, Wozniak MA, Cooper RJ, Wilcock GK, Itzhaki RF. 2002. Herpesviruses in brain and Alzheimer’s disease. J Pathol. 197(3):395–402.
   PubMed Web of Science ®Google Scholar
• Liu D, Dong Y, Liu Z, Niu B, Wang Y, Gao X. 2014. Impact of TREM-2 gene silencing on inflammatory response of endotoxin-induced acute lung injury in mice. Mol Cell Biochem. 394(1-2):155–161.
   PubMed Web of Science ®Google Scholar
• Mangale V, Syage AR, Ekiz HA, Skinner DD, Cheng Y, Stone CL, Brown RM, O'Connell RM, Green KN, Lane TE. 2020. Microglia influence host defense, disease, and repair following murine coronavirus infection of the central nervous system. Glia. 68(11):2345–2360.
   PubMed Web of Science ®Google Scholar
• Marcocci ME, Napoletani G, Protto V, Kolesova O, Piacentini R, Li Puma DD, Lomonte P, Grassi C, Palamara AT, De Chiara G. 2020. Herpes simplex virus-1 in the brain: the dark side of a sneaky infection. Trends Microbiol. 28(10):808–820.
   PubMed Web of Science ®Google Scholar
• Martirosyan A, Moreno E, Gorvel JP. 2011. An evolutionary strategy for a stealthy intracellular Brucella pathogen. Immunol Rev. 240(1):211–234.
   PubMed Web of Science ®Google Scholar
• Mayer-Barber KD, Barber DL. 2015. Innate and adaptive cellular immune responses to Mycobacterium tuberculosis infection. Cold Spring Harb Perspect Med. 5:a018424.
   PubMed Web of Science ®Google Scholar
• McQuade A, Kang YJ, Hasselmann J, Jairaman A, Sotelo A, Coburn M, Sepideh K, Shabestari J, Paul Chadarevian G, Fote CH, et al. 2020. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer’s disease. Nat Commun. 11(1):5370.
   PubMed Web of Science ®Google Scholar
• Möhle L, Israel N, Paarmann K, Krohn M, Pietkiewicz S, Müller A, Lavrik IN, Buguliskis JS, Schott BH, Schlüter D, et al. 2016. Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes. Acta Neuropathol Commun. 4:25.
   PubMed Web of Science ®Google Scholar
• Montalbetti L, Ratti MT, Greco B, Aprile C, Moglia A, Soragna D. 2005. Neuropsychological tests and functional nuclear neuroimaging provide evidence of subclinical impairment in Nasu-Hakola disease heterozygotes. Funct Neurol. 20(2):71–75.
   PubMed Web of Science ®Google Scholar
• Elsa-Noah ND, Branda CS, Branda SS, Nevarez L, Colonna M, Lowell C, Hamerman JA, Seaman WE. 2009. TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J Cell Biol. 184:215–223.
   PubMed Web of Science ®Google Scholar
• Nayeri T, Sarvi S, Sharif M, Daryani A. 2021. Toxoplasma gondii: a possible etiologic agent for Alzheimer’s disease. Heliyon. 7(6):e07151.
   PubMed Web of Science ®Google Scholar
• Ortega M, Ances BM. 2014. Role of HIV in amyloid metabolism. J Neuroimmune Pharmacol. 9(4):483–491.
   PubMed Web of Science ®Google Scholar
• Parlog A, Harsan LA, Zagrebelsky M, Weller M, von Elverfeldt D, Mawrin C, Korte M, Dunay IR. 2014. Chronic murine toxoplasmosis is defined by subtle changes in neuronal connectivity. Dis Model Mech. 7(4):459–469.
   PubMed Web of Science ®Google Scholar
• Peng Q, Malhotra S, Torchia JA, Kerr WG, Coggeshall KM, Humphrey MB. 2010. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal. 3(122):ra38.
   PubMed Web of Science ®Google Scholar
• Perrigoue JG, Marshall FA, Artis D. 2008. On the hunt for helminths: innate immune cells in the recognition and response to helminth parasites. Cell Microbiol. 10(9):1757–1764.
   PubMed Web of Science ®Google Scholar
• Phongsisay V, Iizasa E, Hara H, Yoshida H. 2015. Evidence for TLR4 and FcRγ-CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors. Mol Immunol. 66(2):463–471.
   PubMed Web of Science ®Google Scholar
• Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, Rinker J, 2nd, Naismith RT, Panina-Bordignon P, Passini N, et al. 2008. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain. 131(Pt 11):3081–3091.
   PubMedGoogle Scholar
• Qu W, Wang Y, Wu Y, Liu Y, Chen K, Liu X, Zou Z, Huang X, Wu M. 2018. Triggering receptors expressed on myeloid cells 2 promotes corneal resistance against Pseudomonas aeruginosa by inhibiting caspase-1-dependent pyroptosis. Front Immunol. 9:1121.
   PubMed Web of Science ®Google Scholar
• Quan DN, Cooper MD, Potter JL, Roberts MH, Cheng H, Jarvis GA. 2008. TREM-2 binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cells. Mucosal Immunol. 1(3):229–238.
   PubMed Web of Science ®Google Scholar
• Readhead B, Haure-Mirande JV, Funk CC, Richards MA, Shannon P, Haroutunian V, Sano M, Liang WS, Beckmann ND, Price ND, et al. 2018. Multiscale analysis of independent Alzheimer’s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron. 99(1):64–82.e7.
   PubMed Web of Science ®Google Scholar
• Reyes JL, Terrazas CA, Vera-Arias L, Terrazas LI. 2009. Differential response of antigen presenting cells from susceptible and resistant strains of mice to Taenia crassiceps infection. Infect Genet Evol. 9(6):1115–1127.
   PubMed Web of Science ®Google Scholar
• Rivest S. 2015. TREM2 enables amyloid β clearance by microglia. Cell Res. 25(5):535–536.
   PubMed Web of Science ®Google Scholar
• Rosseau S, Hocke A, Mollenkopf H, Schmeck B, Suttorp N, Kaufmann SH, Zerrahn J. 2007. Comparative transcriptional profiling of the lung reveals shared and distinct features of Streptococcus pneumoniae and influenza A virus infection. Immunology. 120(3):380–391.
   PubMed Web of Science ®Google Scholar
• Ruiz de Morales JMG, Puig L, Daudén E, Cañete JD, Pablos JL, Martín AO, Juanatey CG, Adán A, Montalbán X, Borruel N, et al. 2020. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies. Autoimmun Rev. 19(1):102429.
   PubMed Web of Science ®Google Scholar
• Salminen A, Kaarniranta K, Kauppinen A. 2021. Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: potential role in Alzheimer’s pathogenesis. Neurochem Int. 150:105186.
   PubMed Web of Science ®Google Scholar
• Sarli G, D’Annunzio G, Gobbo F, Benazzi C, Ostanello F. 2021. The role of pathology in the diagnosis of swine respiratory disease. Vet Sci. 8:256.
   PubMedGoogle Scholar
• Schmid CD, Sautkulis LN, Danielson PE, Cooper J, Hasel KW, Hilbush BS, Sutcliffe JG, Carson MJ. 2002. Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem. 83(6):1309–1320.
   PubMed Web of Science ®Google Scholar
• Sek AC, Percopo CM, Boddapati AK, Ma M, Geslewitz WE, Krumholz JO, Lack JB, Rosenberg HF. 2021. Differential expression of Triggering Receptor Expressed on Myeloid cells 2 (Trem2) in tissue eosinophils. J Leukoc Biol. 110(4):679–691.
   PubMed Web of Science ®Google Scholar
• Shafi S, Singh A, Ibrahim AM, Alhajri N, Abu Izneid T, Pottoo FH. 2021. Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias. Eur J Neurosci. 53(10):3294–3310.
   PubMed Web of Science ®Google Scholar
• Sharif O, Gawish R, Warszawska JM, Martins R, Lakovits K, Hladik A, Doninger B, Brunner J, Korosec A, Schwarzenbacher RE, et al. 2014. The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia. PLoS Pathog. 10(6):e1004167.
   PubMed Web of Science ®Google Scholar
• Shirey KA, Perkins DJ, Lai W, Zhang W, Fernando LR, Gusovsky F, Blanco JCG, Vogel SN. 2019. Influenza “Trains” the host for enhanced susceptibility to secondary bacterial infection. mBio. 10:e00810–e00819.
   PubMed Web of Science ®Google Scholar
• Singh H, Rai V, Nooti SK, Agrawal DK. 2021. Novel ligands and modulators of triggering receptor expressed on myeloid cells receptor family: 2015–2020 updates. Expert Opin Ther Pat. 31(6):549–561.
   PubMed Web of Science ®Google Scholar
• Siskind S, Brenner M, Wang P. 2022. TREM-1 modulation strategies for sepsis. Front Immunol. 13:907387.
   PubMed Web of Science ®Google Scholar
• Sun G-Y, Guan C-X, Zhou Y, Liu Y-P, Li S-F, Zhou H-F, Tang C-Y, Fang X. 2011. Vasoactive intestinal peptide re-balances TREM-1/TREM-2 ratio in acute lung injury. Regul Pept. 167(1):56–64.
   PubMedGoogle Scholar
• Sun M, Zhu M, Chen K, Nie X, Deng Q, Hazlett LD, Wu Y, Li M, Wu M, Huang X. 2013. TREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway. Invest Ophthalmol Vis Sci. 54(5):3451–3462.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Rochford CD, Neumann H. 2005. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med. 201(4):647–657.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell. 140(6):805–820.
   PubMed Web of Science ®Google Scholar
• Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. 2011. Pattern recognition receptors and the innate immune response to viral infection. Viruses. 3(6):920–940.
   PubMed Web of Science ®Google Scholar
• Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, Hernandez M, Colonna M. 2006. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol. 177(6):3520–3524.
   PubMed Web of Science ®Google Scholar
• Ulrich JD, Finn MB, Wang Y, Shen A, Mahan TE, Jiang H, Stewart FR, Piccio L, Colonna M, Holtzman DM. 2014. Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2. Mol Neurodegener. 9:20.
   PubMed Web of Science ®Google Scholar
• Ulrich JD, Holtzman DM. 2016. TREM2 function in Alzheimer’s disease and neurodegeneration. ACS Chem Neurosci. 7(4):420–427.
   PubMed Web of Science ®Google Scholar
• Vagima Y, Gur D, Erez N, Achdout H, Aftalion M, Levy Y, Zauberman A, Tidhar A, Gutman H, Lazar S, et al. 2020. Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments. Sci Rep. 10(1):19116.
   PubMed Web of Science ®Google Scholar
• Venugopal PG, Nutman TB, Semnani RT. 2009. Activation and regulation of toll-like receptors (TLRs) by helminth parasites. Immunol Res. 43(1–3):252–263.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S, Zinselmeyer BH, et al. 2015. TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model. Cell. 160(6):1061–1071.
   PubMed Web of Science ®Google Scholar
• Weehuizen TA, Hommes TJ, Lankelma JM, de Jong HK, Roelofs JJ, de Vos AF, Colonna M, van der Poll T, Wiersinga WJ. 2016. Triggering receptor expressed on myeloid cells (TREM)-2 impairs host defense in experimental melioidosis. PLoS Negl Trop Dis. 10(6):e0004747.
   PubMed Web of Science ®Google Scholar
• Wei P, Lu Q, Cui G, Guan Z, Yang L, Sun C, Sun W, Peng Q. 2015. The role of TREM-2 in internalization and intracellular survival of Brucella abortus in murine macrophages. Vet Immunol Immunopathol. 163(3–4):194–201.
   PubMed Web of Science ®Google Scholar
• Won KJ, Park SW, Lee S, Kong IK, Chae JI, Kim B, Lee EJ, Kim DK. 2015. A new triggering receptor expressed on myeloid cells (TREM) family member, TLT-6, is involved in activation and proliferation of macrophages. Immune Netw. 15(5):232–240.
   PubMed Web of Science ®Google Scholar
• Wu K, Byers DE, Jin X, Agapov E, Alexander-Brett J, Patel AC, Cella M, Gilfilan S, Colonna M, Kober DL, et al. 2015. TREM-2 promotes macrophage survival and lung disease after respiratory viral infection. J Exp Med. 212(5):681–697.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang M, Yin H, Ming S, Li X, Jiang G, Liu Y, Wang P, Zhou G, Liu L, Gong S, et al. 2021. TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection. Sci Adv. 7(50):eabi6802.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wu M, Ming S, Zhan X, Hu S, Li X, Yin H, Cao C, Liu J, Li J, et al. 2021. TREM-2 promotes Th1 responses by interacting with the CD3ζ-ZAP70 complex following Mycobacterium tuberculosis infection. J Clin Invest. 131:e137407.
   PubMed Web of Science ®Google Scholar
• Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J. 2013. Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and γ-secretase-dependent intramembranous cleavage*. J Biol Chem. 288(46):33027–33036.
   PubMed Web of Science ®Google Scholar
• Xie M, Liu YU, Zhao S, Zhang L, Bosco DB, Pang YP, Zhong J, Sheth U, Martens YA, Zhao N, et al. 2022. TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration. Nat Neurosci. 25(1):26–38.
   PubMed Web of Science ®Google Scholar
• Yang J, Fu Z, Zhang X, Xiong M, Meng L, Zhang Z. 2020. TREM2 ectodomain and its soluble form in Alzheimer’s disease. J Neuroinflammation. 17(1):204.
   PubMed Web of Science ®Google Scholar
• Zhai Q, Li F, Chen X, Jia J, Sun S, Zhou D, Ma L, Jiang T, Bai F, Xiong L, et al. 2017. Triggering receptor expressed on myeloid cells 2, a novel regulator of immunocyte phenotypes, confers neuroprotection by relieving neuroinflammation. Anesthesiology. 127(1):98–110.
   PubMed Web of Science ®Google Scholar
• Zhang Y, He J, Zheng H, Huang S, Lu F. 2019. Association of TREM-1, IL-1β, IL-33/ST2, and TLR expressions with the pathogenesis of ocular toxoplasmosis in mouse models on different genetic backgrounds. Front Microbiol. 10:2264.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, Sun Y, Zhu B, Piña-Crespo JC, Zhang M, Zhang N, et al. 2018. TREM2 is a receptor for β-amyloid that mediates microglial function. Neuron. 97(5):1023–1031.e7.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zheng H, Chen Y, Zhang L, Wang K, Guo J, Huang Z, Zhang B, Huang W, Jin K, et al. 2009. Chistosoma japonicum genome sequencing and functional analysis consortium. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature. 460(7253):345–351.
   Google Scholar
• Zhu M, Li D, Wu Y, Huang X, Wu M. 2014. TREM-2 promotes macrophage-mediated eradication of Pseudomonas aeruginosa via a PI3K/Akt pathway. Scand J Immunol. 79(3):187–196.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhang X, Dong W, Wang X, He S, Zhang H, Wang X, Wei R, Chen Y, Liu X, et al. 2020. TREM2 suppresses the proinflammatory response to facilitate PRRSV infection via PI3K/NF-κB signaling. PLoS Pathog. 16(5):e1008543.
   PubMed Web of Science ®Google Scholar